← Browse by Condition
Medical Condition
hormone receptor positive breast cancer
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 4
NCT06388122
Recruiting
DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Metastatic Breast Cancer Patients
Enrollment
100 pts
Location
United States
Sponsor
Mayo Clinic
NCT05452213 Phase 4
Recruiting
Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients
Enrollment
1,000 pts
Location
Germany
Sponsor
Institut fuer Frauengesundheit